Skip to content
Open access

Early Detection of Parkinson’s Disease Using Parametric Features and Advanced fMRI Analysis

Sep 2026 · Technologies · 0 citations · 32 references

TL;DR

Results demonstrate the effectiveness of the preprocessing strategy and its potential as a non-invasive biomarker for early PD detection, even with reduced input data, and suggest that high classification performance can be achieved with a limited number of fMRI slices, facilitating data acquisition and reducing subject burden in clinical studies.

Abstract

According to the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder among older adults, surpassed only by Alzheimer’s disease. PD is characterized by a heterogeneous combination of motor and non-motor symptoms, with involuntary movements constituting a central clinical defining feature. The prodromal phase presents substantial diagnostic challenges, as early symptoms are often mild, nonspecific, and commonly misinterpreted because overt motor signs are absent. Significantly, these early alterations can precede formal diagnosis by up to two decades, highlighting the urgent need for effective early detection strategies. In this work, we propose a functional Magnetic Resonance Imaging (fMRI)-based image-processing and machine learning framework for early detection of PD. Statistical features are extracted to train a set of 25 machine learning kernels, from which the most accurate model is selected. We then apply the Minimum Redundancy Maximum Relevance (mRMR) algorithm to identify the most descriptive fMRI frames for each subject. We introduce a hierarchical classification strategy: an initial binary classification to distinguish control subjects from prodromal + PD cases, followed by a second binary classification to discriminate between Prodromal and PD. The experimental results demonstrate a maximum precision of 96.3% with 16 axial slices and 86.4% with a single slice, indicating the effectiveness of the preprocessing strategy and its potential as a non-invasive biomarker for early PD detection, even with reduced input data. These findings suggest that high classification performance can be achieved with a limited number of fMRI slices, facilitating data acquisition and reducing subject burden in clinical studies.

Read PDF

Similar papers

Review Sep 2026

Parkinson's disease diagnosis using machine learning and multimodal biomarkers: A systematic review.

Multimodal fusion architectures, particularly cross-attention transformers integrating motor, voice, and gait data, consistently outperformed unimodal approaches by 4%-8% in the area under the receiver operating characteristic curve (AUC), with the largest gains in early stage detection and differential diagnosis tasks...

Muhammad Imran Khan, A. Imran, A. Alshammari · 0 citations
Sep 2026

Diagnosis and Prognosis Perspective of Parkinson's Disease Using Multimodal Artificial Intelligence

Parkinson's disease (PD) demands both accurate early diagnosis and reliable assessment of progression, yet its clinical manifestations are heterogeneous and often become evident only after substantial neurodegeneration has occurred. This paper investigates whether multimodal artificial intelligence (AI) can address the...

Ravikumar Mutyala · 0 citations
Review Open access Oct 2026

Neuromelanin-sensitive magnetic resonance imaging in the diagnosis and assessment of Parkinson’s disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized primarily by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc); noradrenergic neurons in the locus coeruleus (LC) are also frequently affected. Because clinical motor symptoms usually emerge only a...

Die Zhang, A. Yusufujiang, Hong-Yan Li · 0 citations
#explainable ai Open access Oct 2026

Three-Stage Deep Learning Approach for Alzheimer’s and Parkinson’s Disease Detection

Purpose: Diagnosis of Alzheimer's disease (AD) and Parkinson's disease (PD) remains challenging, and existing AI-based neuroimaging tools are typically applied in isolation for diagnosis, multimodal analysis, or progression tracking. This study aims to develop an integrated, three-stage deep learning framework that uni...

S. K. Mohod, R. Thakare · 0 citations
Editorial Open access Aug 2026

Imaging Biomarkers in Parkinson's Disease and Movement Disorders: Emerging Insights from Multimodal Neuroimaging.

While these multimodal biomarkers offer unprecedented mechanistic insights into disease progression and therapeutic response, their ultimate value depends on successful clinical translation, it would be essential for the field to prioritize standardized acquisition protocols, automated post-processing pipelines, and ac...

E. Haacke, S. Buch, Naying He et al. · 0 citations
Open access Sep 2026

Distinct EEG functional network alterations in Parkinson's disease and multiple system atrophy

Parkinson's disease (PD) and multiple system atrophy (MSA) are alpha-synuclein-related neurodegenerative disorders with overlapping motor and non-motor symptoms but distinct pathology, clinical management, and prognosis. Early differential diagnosis, particularly between PD and the parkinsonian subtype of MSA (MSA-P),...

Dai-Chao Chen, Hua-Da Tang, Yan-Fei Pan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.